BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions Read more →
Chutes & Ladders—Former FDA leader takes new biotech Turn Read more →
Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both Read more →
Max Eldridge
Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors